Alexion Pharmaceuticals (ALXN)
Create an AlertAlexion Pharmaceuticals Liabilities:
595.83M for March 31, 2013Alexion Pharmaceuticals Historical Liabilities Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 595.83M |
| Dec. 31, 2012 | 642.71M |
| Sept. 30, 2012 | 633.17M |
| June 30, 2012 | 707.92M |
| March 31, 2012 | 804.18M |
| Dec. 31, 2011 | 260.26M |
| Sept. 30, 2011 | 249.31M |
| June 30, 2011 | 226.07M |
| March 31, 2011 | 253.16M |
| Dec. 31, 2010 | 152.30M |
| Sept. 30, 2010 | 130.44M |
| June 30, 2010 | 97.38M |
| March 31, 2010 | 93.29M |
| Dec. 31, 2009 | 98.04M |
| Sept. 30, 2009 | 124.77M |
| June 30, 2009 | 128.54M |
| March 31, 2009 | 216.93M |
| Dec. 31, 2008 | 230.55M |
| Sept. 30, 2008 | 256.58M |
| June 30, 2008 | 252.39M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Oct. 31, 2005 | Go Pro |
| July 31, 2005 | Go Pro |
| April 30, 2005 | Go Pro |
| Jan. 31, 2005 | Go Pro |
| Oct. 31, 2004 | Go Pro |
| July 31, 2004 | Go Pro |
| April 30, 2004 | Go Pro |
| Jan. 31, 2004 | Go Pro |
| Oct. 31, 2003 | Go Pro |
| July 31, 2003 | Go Pro |
| April 30, 2003 | Go Pro |
| Jan. 31, 2003 | Go Pro |
| Oct. 31, 2002 | Go Pro |
| July 31, 2002 | Go Pro |
| April 30, 2002 | Go Pro |
| Jan. 31, 2002 | Go Pro |
| Oct. 31, 2001 | Go Pro |
| July 31, 2001 | Go Pro |
| April 30, 2001 | Go Pro |
| Jan. 31, 2001 | Go Pro |
| Oct. 31, 2000 | Go Pro |
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More
ALXN Liabilities Benchmarks
| Companies | |
|---|---|
| Biogen Idec | 2.826B |
| Alkermes | 517.92M |
| Anika Therapeutics | 28.53M |
ALXN Liabilities Rankings
| Overall |
64th percentile 5939 of 16782 |
| Sector |
42nd percentile 812 of 1410 in Healthcare |
| Industry |
28th percentile 324 of 454 in Biotechnology |
ALXN Liabilities Range, Past 5 Years
| Minimum | 93.29M | Mar 2010 |
| Maximum | 804.18M | Mar 2012 |
| Average | 307.69M |
